University of Maryland School of Nursing News

For Immediate Release:
August 19, 2004

Contact: Patricia Adams

UNIVERSITY OF MARYLAND SCHOOL OF NURSING TO OFFER MASTER'S DEGREE IN CLINICAL RESEARCH MANAGEMENT

Baltimore, Md. – A new Master of Science (M.S.) program in Clinical Research Management will debut this fall at the University of Maryland School of Nursing. The program was developed in response to the increasing demand for nurse leaders who are able to manage clinical research studies in collaboration with principal investigators - a demand created by the rapid growth in clinical trial research designed to test new pharmacological agents and technical devices as treatments and diagnostic interventions for use in patient care. The Clinical Research Management specialty will address the need for nursing professionals prepared to organize and manage clinical trials through the application of expert knowledge in areas such as protocol interpretation, data monitoring, research ethics and federal regulations.

"The size, scope and complexity of clinical research studies requires leadership, coordination and management by nursing leaders," says Mary Etta Mills, ScD, RN, FAAN, associate dean for academic affairs. "This new program will help prepare nursing professionals for this growing need."

Students can complete the M.S. degree with 30 credits that can be taken part-time or in two semesters of full-time study. A post-master's certificate can be completed with 16 credits of coursework.

Call 410-706-0501 for more information, or visit www.nursing.umaryland.edu.

Founded in 1889, the University of Maryland School of Nursing is one of the leading research institutions in the nation. Consistently ranked among the top 10 schools of nursing in the nation by U.S. News & World Report, the School enrolls over 1,400 students in its baccalaureate, master's, doctoral and continuing education programs. The School emphasizes the integration of research, teaching and clinical practice, and serves regional, national and international audiences.